by Cassidy Morrison at Daily Mail
- A federal watchdog criticized the government’s weak oversight of risky research
- Gain of function research has been thrust into the spotlight thanks to Covid-19
- The group also called out a lack of transparency when it came to funding labs
Poor oversight and loopholes mean risky virus research feared to have started the Covid pandemic in China continues to go on in the US.
That is the damning conclusion of a report — prompted by an explosive DailyMail.com revelation — into rules around ‘gain of function’ studies.
The Congressional watchdog group the Government Accountability Office (GAO) concluded that federal oversight of the most sensitive scientific experimentation was far too weak and ineffective.
In October, this website shockingly revealed that a Boston University team had created a new Covid strain with an 80 percent kill rate in mice, even though questions remain about whether similar experiments led to the release of Covid…
Continue Reading